Five-year follow-up of the phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in patients with HER2 positive early or locally advanced breast cancer
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Five-year follow-up of the phase III study comparing SB3 (trastuzumab biosimilar) and reference trastuzumab in patients with HER2 positive early or locally advanced breast cancer |
| Type de publication | Journal Article |
| Year of Publication | 2021 |
| Auteurs | Pivot X., Burian O., Bazan F., Wojtukiewicz M., Jang H., Kim S., Lee J., Yoon Y.C |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 32 |
| Pagination | S428 |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |
| DOI | 10.1016/j.annonc.2021.08.435 |